USANA Health Sciences (USNA) Misses Q4 EPS by 16c; Issues Light FY16 Outlook
Tweet
Share
E-mailGet Alerts USNA Hot Sheet
Price: $18.90 +0.11%
Revenue Growth %: +0.0%
Financial Fact:
Other income (expense), net: 268K
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: +0.0%
Financial Fact:
Other income (expense), net: 268K
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
USANA Health Sciences (NYSE: USNA) reported Q4 EPS of $1.83, $0.16 worse than the analyst estimate of $1.99. Revenue for the quarter came in at $232.6 million versus the consensus estimate of $238.91 million.
GUIDANCE:
USANA Health Sciences sees FY2016 EPS of $7.60-$8.15, versus the consensus of $8.59. USANA Health Sciences sees FY2016 revenue of $1.02-1.05 billion, versus the consensus of $1.02 billion.
For earnings history and earnings-related data on USANA Health Sciences (USNA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AeroVironment restates quarterly financials, citing $89M goodwill error
- Ennis (EBF) Reports In-Line Q1 EPS
- Goldman reinstates Estee Lauder rating, sees turnaround driving growth and margins
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
